Zika virus infection and
myasthenia gravis: report of 2 cases.
The incidence of
myasthenia gravis: a systematic literature review.
The effect of
myasthenia gravis as a prognostic factor in thymoma treatment.
Myasthenia gravis: a changing pattern of incidence [Electronic version].
Worsening of
myasthenia gravis after administration of injectable long-acting risperidone for treatment of schizophrenia; first case report and a call for caution.
The severity of
myasthenia gravis was assessed by Quantitative
myasthenia gravis score and Osserman and Genkins classification and graded accordingly for prompt care and management.
Pseudointernuclear ophthalmoplegia as a presenting feature of ocular
myasthenia gravis. BMJ Case Rep 2014;2014;bcr2013203234.
Treatment of
myasthenia gravis with reversible acetylcholinesterase inhibitors like pyridostigmine may be associated with potential side effects such as bradyarrhythmias and in rare cases complete asystole and sinus arrest.
A 69-year-old Caucasian female with seropositive
myasthenia gravis on monthly maintenance intravenous immunoglobulin (1gram/kg body weight) every 4 weeks and prednisone 50 mg PO daily and pyridostigmine 60 mg three times a day was transferred to the university hospital cardiology service with acute onset chest pain, palpitations, nausea, and profuse sweating on waking up in the morning at a long-term acute care (LTAC) facility.
Presence of antibodies to the nicotinic acetylcholine receptor (AChR) is most common, with a positive result in 80% of adults with generalized
Myasthenia Gravis [1].